{
    "type": "ETF",
    "ucits": true,
    "fund_name": "L&G FTSE 100\u00ae Super Short Strategy (Daily 2x) UCITS ETF",
    "investment_objective": "Track the performance of the FTSE 100\u00ae Daily Super Short Strategy Index, which provides an inverse multiple (2x) of the daily movement of the FTSE 100\u00ae Total Return Declared Dividend Index.",
    "primary_asset_class": "Equity",
    "geographic_focus": "United Kingdom",
    "replication_method": "synthetic",
    "swaps": true,
    "derivatives": true,
    "leverage": true,
    "inverse": true,
    "complex_factors": [
        "Unfunded total return swaps",
        "2x daily leverage",
        "Inverse leveraged index exposure",
        "Synthetic replication",
        "Counterparty risk",
        "Daily reset and compounding effects"
    ],
    "classification": "complex",
    "supporting_data": "The ETF uses synthetic replication via unfunded total return swap agreements with investment banks to achieve its investment objective. The Fund targets a 2x inverse daily leveraged exposure to the FTSE 100 Total Return Index, which is reset daily, causing compounding effects that make returns non-linear over periods longer than one day. The use of swaps introduces counterparty risk, explicitly disclosed in the KIID and fact sheet. The Fund is UCITS compliant but employs leverage and inverse exposure, both complexity triggers under MiFID II. The risk rating is high (7 out of 7 in KIID, 6 out of 7 in PRIIPs), reflecting the leveraged and synthetic nature of the product. The PRIIPs KID also highlights the product is designed for short-term investors who understand leveraged risks and can bear total loss. The fact sheet confirms synthetic replication, unfunded swap structure, and daily reset of leverage. No capital protection or structured features are present, but the leverage, swap usage, and inverse exposure clearly classify this ETF as complex under MiFID II rules.",
    "risk_level_assessment": "The Fund's risk rating is at the highest levels (7 in KIID, 6 in PRIIPs), consistent with the complexity arising from leverage, synthetic replication, and counterparty risk. The product is not suitable for long-term holding or investors unfamiliar with leveraged inverse ETFs. The risk disclosures emphasize magnified losses, counterparty risk, and the potential for significant deviation from underlying index performance over time due to daily resetting and compounding effects."
}